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 High antigenic variability in the envelope (E) protein of different virus strains has been a major obstacle in 
designing effective vaccines for Dengue virus (DENV). To maintain their biological function, some parts of 
viral proteins remain stable during evolution thus one possible approach to solve this problem is to recognize 
specific regions within different protein sequences of E that have the tendency to stay constant through 
evolution. These regions may possess some special attributes to become a vaccine candidate against dengue 
virus. In this study, a computational approach was utilized to identify and analyze highly conserved amino acid 
sequences of the DENV E protein. Sequences of 9 amino acids or more were specifically focused due to their 
immune-relevant as T-cell determinants. Different bioinformatics tools were responsible for revealing 
conserved regions in the DENV E protein and constructing the phylogenetic tree from the sequence database. 
The tools also predicted immunogenicity of the identified vaccine targets. Ultimately, two peptide regions of at 
least 9 amino acids were chosen due to their high conserved attribute in more than 95% of all collected DENV 
sequences. Moreover, both of them was found to be immune-relevant by their correspondence to known or 
putative HLA-restricted T cell determinants. The conserved attribute of these sequences through the entire 
analysis of this study supports their potential as candidates for further in vitro experiments for rational design a 
universal vaccine which has longer and broader impact. 
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INTRODUCTION 
 Dengue is currently listed as one of the 
neglected tropical diseases even though it has 
plagued human populations for at least 250 years 
(Hotez et al., 2014). Millions of people are at risk of 
infections that may lead to fatal symptoms such as 
Dengue Fever (DF) and Dengue Hemorrhagic Fever 
(DHF). An estimated 50% of the global human 
population is exposed to dengue fever transmitted by 
the Aedes aegypti or Ae. albopictus mosquito 
(Rigau-Pérez et al., 1998). Up to now, dengue virus 
(DENV) has spread to more than 100 countries, 
mainly tropical and subtropical areas. Statisticians 
estimated that there are millions of infections and 
thousands of deaths caused by DENV each year 
(Gubler et al., 2014). 
 The dengue is caused by dengue viruses 
(DENV), which form the dengue complex in the 
genus Flavivirus, family Flaviviridae. There are four 
serologically distinct types of dengue virus: DENV-
1, DENV-2, DENV-3, and DENV-4. There are three 
main structural proteins of DENV: capsid, pre-
membrane (prM), and envelope (E) protein. One 
potential way to develop vaccines against DENV 
entry focused on E protein (Murrell et al., 2011). It 
is because E protein assumes different conformations 
in the life cycle of the virus (Kuhn et al., 2002; Rey, 
2003; Perera & Kuhn, 2008). Therefore, it is thought 
to be responsible for many important roles such as 
mediating viral entry by interacting with host cell 
surface receptors (Rey, 2003). E protein is also the 
primary target of adaptive immune response 
(Murphy & Whitehead, 2011). 
 Many approaches have been directed at the 
DENV E protein such as viral receptors, 
hydrophobic pockets, monoclonal antibodies 
(Murrell et al., 2011). However, none of these 
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studies demonstrated an effective way to combat 
DENV due to various reasons (Murrell et al., 2011). 
The most common obstacles are the lack of 
knowledge of DENV E protein involvement in the 
infection process and the high variability of DENV 
(Murrell et al., 2011). Currently, there is no licensed 
vaccine, antiviral drugs or specific treatment against 
dengue (Gubler et al., 2014). Preventive measures 
are the best strategy, which consists mainly of 
environmental management, spraying insecticides, 
and personal protective measures (Murrell et al., 
2011; Mustafa et al., 2015). 
 In recent years, the fields of bioinformatics and 
immune-informatics are emerging rapidly suggesting 
alternative solutions to the DENV problems. Many 
complex problems such as understanding immune 
responses and vaccine/drug design have been solved 
with the combinations of experimental and in silico 
methods (Korber et al., 2006). Bioinformatics tools 
have the ability to systematically scan for candidate 
epitopes from larger sets of protein antigens such as 
those encoded by complete viral genomes. 
Considerable time and costs could be saved by this 
approach. The strategy of computer-aided vaccine 
design seems to be quite effective in dealing diseases 
such as multiple sclerosis (Bourdette et al., 2005), 
malaria (López et al., 2001), and tumors (Knutson et 
al., 2001). 
 With the advent of computer-aided vaccine 
design method, a throughout investigation of 
epitopes on DENV E protein using bioinformatics 
tools is necessary for understanding viral function 
and for the design of unique polyvalent vaccines 
capable of inducing a neutralizing antibody response 
against each DENV serotype. In this study, the E 
protein from all four types of dengue virus was 
analyzed using bioinformatics and immune-
informatics tools for identification of an 
immunogenic hot spot that may be used as a peptide 
vaccine candidate. 
MATERIALS AND METHODS 
Data collection 
 
 To obtain maximum geographical and 
chronological diversity, the envelope protein 
sequences from many variants belong to all 4 type of 
dengue virus (DENV-1, DENV-2, DENV-3 and 
DENV-4) were retrieved from Uniport protein 
database (www.uniprot.org) (Consortium, 2014). 
Different variants of E protein (isolated from 
different geographical locations in different time 
points) were manually selected from the above 
proteomics database (Table 1). The following criteria 
were used when compiling the database (Twiddy et 
al., 2003; Costa et al., 2012): (1) all sequences had a 
known date of collection and geographic location; 
(2) sequences collected in the same year from the 
same geographical location were excluded. This 
resulted in a most updated database of 688 DENV E 
protein sequences from 78 countries covering the 
temporal range of 51 years (1961 – 2012). 
Table 1. Characteristics of DENV database used in this 
study. 
Serotype Number of sequences 
Time intervals 
(years) 
DENV-1 131 1972-2012 
DENV-2 218 1969-2012 
DENV-3 184 1974-2012 
DENV-4 155 1961-2012 
 
Multiple sequence alignment  
 The alignments were generated on the basis of 
different algorithms of multiple sequence alignment 
calculation for higher accuracy and consistency. 
Sequences were first aligned in MUSCLE (Edgar, 
2004), and then the alignment was verified and 
corrected if necessary in 3 other different algorithms 
which have been widely used and previously proved 
accurate in MSA: CLUSTALW (Thompson et al., 
2002), MAFFT (Katoh et al., 2002) and Kalign 
(Lassmann & Sonnhammer, 2005). All of these 
algorithms were already integrated into Unipro 
UGENE package upon installation for the ease of 
use (Okonechnikov et al., 2012). 
 
Construction of phylogenetic tree 
 The multiple sequence alignment (MSA) was 
generated from the retrieved protein sequences. This 
MSA formed the basis for construction of 
phylogenetic tree, which was used to elucidate the 
evolutionary distance among the envelope proteins 
as well as to identify the conserved regions in the 
envelope proteins. Unipro UGENE package was 
employed to construct and visualize the un-rooted 
phylogenetic tree (Okonechnikov et al., 2012). 
MUSCLE was utilized for generating MSA and 
PHYLIP neighbor-joining method was used for the 
construction of phylogenetic tree (Edgar, 2004). 
Evolutionary distances that were used to infer the 
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phylogenetic tree were computed using the Kimura 
distance matrix model with 1000 bootstrap replicates 
(Lockhart et al., 1994). 
Identification of conserved regions, termed as 
pan-DENV sequences 
 The DENV protein sequences were examined by 
a consensus sequence based approach (Novitsky et 
al., 2002) to identify sequence fragments that were 
common across the 4 types. These conserved 
sequence fragments are also known as pan-DENV 
sequences. The consensus sequences for the 
envelope protein of each type (intra-type consensus) 
were first derived by multiple sequence alignments 
to select the predominant residue at each amino acid 
position. The 4 intra-type consensus sequences for 
envelope protein (one from each type) were then 
aligned to reveal sequence fragments identical across 
each of the types that were at least 9 amino acids 
long. Only sequence fragments that were identical in 
at least 80% of the sequences of each of the 4 types 
were retained for further analyses. 
Information entropy analysis of pan-DENV 
sequences 
 Shannon information entropy ( Strait & Dewey, 
1996; Khan et al., 2006) was used to study the 
diversity of DENV protein sequences within each 
type (intra-type diversity) and across all DENVs 
(pan-DENV diversity) and to assess the predicted 
evolutionary stability of the identified pan-DENV 
sequences. Entropy, H, representing the variability of 
nonamer peptides (peptides that are composed of 9 
amino acids) centered at any given alignment site, is 
computed from the probability, pa of each nonamer 




 All entropy analyses were carried out by using 
BioEdit (Hall, 1999). 
Functional and structural correlates analyses of 
pan-DENV sequences 
 The known and putative structural and 
functional properties of pan-DENV sequences were 
elucidated by used of the Prosite (Hulo et al., 2006), 
via ScanProsite (Gattiker et al., 2002), and Pfam 
(Punta et al., 2011) databases which comprise 
information on protein families, domains and 
functional site. Then, conserved sequences were 
mapped on the three-dimensional (3-D) structures of 
DENV in the PDB database (Sussman et al., 1998) 
by use of ConSurf (Armon et al., 2001). The 
variability pattern plotted on the DENV envelope 
protein structure was visualized by UCSF Chimera 
package (Pettersen et al., 2004). The PDB ID of 3-D 
crystal structures of DENV-1, DENV-2, DENV-3 
and DENV-4 envelope protein used in this study 
respectively were 3G7T, 1OAN, 1UZG, and 3UAJ 
(Sussman et al., 1998). 
Identification of pan-DENV sequences common 
to other viruses and organisms 
 Pan-DENV sequences that overlapped at least 9 
consecutive amino acid sequences of other viruses 
and organisms were identified by performing 
BLAST (Altschul et al.,1997) search against viral 
protein sequences reported at NCBI, excluding 
DENV sequences, and against protein sequences of 
all organisms excluding viruses (Boratyn et al., 
2012). This process was completed by choosing 
“Exclude” option in “Organism” field for Dengue 
virus (taxid: 10052 and 12637); Dengue virus 1 
(taxid: 11053); Dengue virus 2 (taxid: 11060), 
Dengue virus 3 (taxid: 11069) and Dengue virus 4 
(taxid: 11070). 
Identification of known and predicted pan-DENV 
HLA super-type binding sequences 
 The Immune Epitope Database (IEDB: 
www.iedb.org) (Vita et al., 2010) were utilized to 
conduct series of search for reported immunogenic, 
human T-cell determinants (both class I and II) of 
DENV that either fully or partially overlapped with the 
pan-DENV sequences. Moreover, dedicated algorithms 
based on several prediction models were used to 
identify candidate putative HLA-binding sequences to 
multiple HLA class I and II supertype alleles within the 
pan-DENV sequences. Putative HLA supertypes class 
I-restricted peptides were identified by NetCTL (Larsen 
et al., 2005); Artificial neural network (ANN) (Nielsen 
et al., 2003); Stabilized matrix method (SMM) (Peters, 
Sette, 2005), and class II-restricted peptides by NN-
align (Nielsen, Lund, 2009) and SMM-align (Nielsen et 
al., 2007). 
RESULTS AND DISSCUSSION 
Multiple sequence alignment  
 The DENV E protein sequences generally 
exhibit low intra-type but high inter-type variability. 
More than 3/4 amino acid positions are highly 
conserved (≥ 80% identity) within each serotype. 
Phuc Nguyen & Ly Le	
608 
However, when the whole 688 sequences are 
aligned, this level of conservation is significantly 
reduced (≈ 60% identity). 
Evolution divergence of the DENV E protein 
 E protein sequences from 691 variants belonging 
to 4 types of dengue virus were retrieved from the 
database. MSA generated from these sequences were 
exploited to construct a phylogenetic tree which 
showed the evolutionary divergence among the 
envelope protein sequences. A significant 
evolutionary divergence was observed in the 
phylogram obtained for the E proteins. Most of the 
four serotypes of DENV were clearly arranged in 
well-define clades with high statistical support 
(Figure 1). In this result, DENV-1 is closest to the 
hypothetical ancestor, thus, it may be least evolved 
member in the group. However, when comparing 
DENV-1 with DENV-4 and DENV-3 clusters, the 
distances among them are not significant, possibly 
meaning that these 3 stereotypes show little 
differences in their sequence composition (Figure 1). 
Overall, DENV-4 is the most evolved and divergent 
among the 4 serotypes. This high variety in DENV-4 
sequences may create great obstacles in development 











Conserved pan-DENV sequences 
 From the outputs of the MSA, there were 2 
pan-DENV sequences of at least 9 amino acids 
that were present in ≥80% of all sequences of each 
DENV type (Figure 2; Table 2). The size of the 
pan-DENV sequences ranged from 10 to 15, with 
a combined size of 25 residues, corresponding 
approximately to 5% of the complete DENV E 














Table 2. The intra-type percentage representation of pan-DENV sequences. a Amino acid positions numbered according to 
the sequence alignments of the 4 DENV types; b Rounded to 1 decimal place. 
 
DENV protein Pan-DENV sequence a 
% intra-type representation b 
DENV-1 DENV-2 DENV-3 DENV-4 
E 97-111 97VDRGWGNGCGLFGKG111 100 99.5 99.5 99.4 
E 252-261 252VLGSQEGAMH261 99.2 99.1 100 100 
 
 
Evolutionary diversity of DENV protein nonamer 
peptide sequences 
 By applying Shannon information entropy, 
the evolutionary diversity of each DENV type, 
and all of 4 serotypes, was investigated (Strait, 
Dewey, 1996). The result showed numerous long 
regions of low entropy (≤1), illustrating the 
relatively high degree of intra-type sequence 
conservation. In general, the average intra-type 
nonamer entropy value of E protein of DENV-1, 
-2, -3 and 4 approximately ranged from 0.05 to 1 
Figure 1. Summarized DENV phylogeny, picturing the 
evolution of the serotypes. 
	
Figure 2. Pan-DENV sequences and their representations in the 4 DENV types. The 2 pan-DENV sequences of at least 9 
amino acids that were found present ≥80% of the collected sequences of each DENV type are shown. Amino acid positions 
were numbered according to the sequence alignments of the 4 DENV types. 
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(Figure 3; Table 3). Both of the 2 pan-DENV 
sequences identified earlier had entropy value 
≤0.3 corresponding to the intra-type 
representation ≥90% (Khan et al., 2006). 
Therefore, by applying appropriate consensus- 
and entropy-based analyses, highly conserved 
and evolutionary stable pan-DENV sequences in 
E proteins are illuminated, in spite of the distinct 
viral diversity defining multiple DENV variants 






















































































Table 3. Pan-DENV sequences, entropy and representation of variants. a Amino acid positions numbered according to the 
sequence alignments of the 4 DENV types; b Maximum nonamer peptide entropy across all DENV sequences (rounded to 1 
decimal place); c Minimum and maximum percentage representation of sequences that different from pan-DENV sequences  
in the whole database (rounded to whole number). 
 
DENV protein Pan-DENV sequence a Peptide entropy b % variant representation c 
E 97-111 97VDRGWGNGCGLFGKG111 0.2 1 
E 252-261 252VLGSQEGAMH261 0.2 1 
 
Functional and structural correlates of the pan-
DENV sequences 
 Critical sites and domains are likely to be 
represented by highly conserved protein sequences 
(Valdar, 2002). A search of the literature and the 
Prosite and Pfam databases (Hulo et al., 2006; Punta 
et al., 2011) revealed that both of the identified pan-
DENV sequences were associated with biological 
activities (Table 4). They are corresponded to the 
fusion peptide (position 98 to 110) and dimerization 
domain (Allison et al., 2001; Modis et al., 2004). 
 It is generally recognized that amino acids 
buried inside proteins are subject to greater 
interactions and packing constraints than those 
exposed on the outer surface (Haydon & Woolhouse, 
1998). The mutational variability was investigated 
and visualized with the aid of ConSurf (Glaser et al., 
2003). Based on the Consurf results, both of the pan-
DENV sequences were exposed at the surface of the 
corresponding structures but still fairly conserved 
(Figure 4). In addition, there were little differences 
among the 3-D structure of each DENV type. 
D 
E 
Figure 3. Shannon entropy of nonamer peptides within and across DENV type sequences. The entropy values were 
computed from the alignments of DENV sequences using the BioEdit software. Values were plotted for all 4 DENV types 
(A), DENV-1 (B), DENV-2 (C), DENV-3 (D), and DENV-4 (E) sequences. The triangles below indicate the locations of the 
pan-DENV sequences in the corresponding proteins. 
 























































A1 and A2 
	
B1 and B2 
	























































D1 and D2 
	
C1 and C2 
	
Figure 4. The mutational variability color scale plotted on the chain A of protein structure of each DENV type with the aid of 
Consurf and visualized by Chimera. There are 2 sub-figures for each DENV type; one is for mapping the location of pan-
DENV sequences on the DENV 3-D structure (colored in blue) and the other to illustrate the conserved level of pan-DENV 
sequences calculated by Consurf (results based on the colors):  DENV-1 (A1, A2); DENV-2 (B1, B2); DENV-3 (C1, C2) and 
DENV-4 (D1, D2). 
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Table 4. Functional and structural properties of pan-DENV sequences. a Amino acid positions numbered according to the 
sequence alignments of the 4 DENV types; b Described in the literature and/or identified using the Prosite (Hulo et al,., 2006) 
and Pfam (Bateman et al.,, 2004) databases. Prosite (PS) and Pfam (PF) accession numbers: PS00008, N-Myristoylation; 




Pan-DENV sequence a Functional domains and motifs b Putative post-transcriptional 
modifications b 
E 97-111 97VDRGWGNGCGLFGKG111 Dimerization Domain, Fusion 
Peptide 
N-Myristoylation 
E 252-261 252VLGSQEGAMH261 Dimerization Domain - 
 
Distribution of pan-DENV sequences in nature 
 The 2 identified pan-DENV sequences 
overlapped at least 9 amino acid sequences of as many 
as 25 other viruses of the family Flaviviridae, genus 
Flavivirus including Apoi, Banzi, Bouboui, Duck 
flavivirus, Edge Hill, Entebbe bat virus, Kedougou, 
Kokobera, Kunjin, Louping ill, Montana myotis 
leukoencephalitis, New Mapoon, Rio Bravo, Sepik, 
Spondweni, St. Louis encephalitis, Stratford Yellow 
fever, Tick-borne encephalitis, Uganda, West Nile, 
Wesselbron, Yokose, Zika virus. Most of the 
sequences from these species were also belong to the 
E protein of Flavivirus (DENV also belongs to this 
genus), thus, associated dimerization/fusion domains. 
The number of the overlapped E 97-111 sequences 
was high among known sequences of several of the 
highly studied Flaviviruses: Kunjin, St. Louis 
encephalitis, Tick-borne encephalitis, West Nile, 
Yellow fever and Zika viruses (Table 5). 
 
Table 5. Distribution of pan-DENV sequences in nature. a Amino acid positions numbered according to the sequence 
alignments of the 4 DENV types; b Species (#) column indicates the number of viral species that shared at least 9 
consecutive amino acids of the pan-DENV sequence; c Percentage representation is only shown for viral species with ≥ 10 
total sequences reported at the NCBI Entrez protein database. These viral species included: LEV, St. Louis encephalitis 




Species (#) b Percentage representation (%)/ number of sequence analyzed c 
LEV WNV TBEV YFV KJ ZV 
E 97-111 22 100/27 100/149 87/229 93/261 100/36 _ 




Known and predicted HLA supertype-restricted, 
pan-DENV T-cell determinants 
 Literature survey and database search revealed 
that 1 of the pan-DENV sequences (E 252-261) 
overlapped at least 9 amino acids of 1 previously 
reported DENV T-cell determinants immunogenic in 
human, KKQDVVVLGSQEGAM, the amino acids 
present in E 252-261 are underlined (Simmons et al., 
2005). Further evaluation of the immune-relevance 
of the pan-DENV sequences included a search for 
candidate putative promiscuous HLA supertype-
restricted T-cell determinants within E 97-111 and E 
252-261 by use of several computational algorithms 
described in the Methods. In general, both pan-
DENV sequences, identified in E protein were 
predicted to contain 6 HLA class I supertype-
restricted nonamers only, no class II-restricted 
peptides were identified (Table 6). Most of the 
predicted promiscuous HLA-binding nonamer were 
present in ≥95% of the sequences of each DENV 
type (Table 7). Clusters (hotspots) of two or more 
overlapping HLA-binder nonamer core peptide were 
present in both of the putative supertype pan-DENV 
sequences, mostly in E 97-111. These clusters 
contained 3 or more nonamer binders overlapping by 
7 or 8 amino acids, covering most corresponding 
conserved region. 
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Table 6. Candidate putative HLA supertype-restricted binding nonamer peptides in pan-DENV sequences, predicted by 
immune-informatic algorithms. a Amino acid positions of the pan-DENV sequences and the predicted nonamers are 
numbered according to the sequence alignments of the 4 DENV types; b HLA supertype-restrictions that were predicted by at 
least two prediction models are highlighted in bold; c Peptides specific to HLA class I supertypes were predicted by use of 
NetCTL (A24, B7), ANN (A03, A01, A24) and SMM (A01, A03, A24, B27, B62); d Sequences identified as specific to class II 
were predicted by use of NN-align and SMM-align as described in methods. 
 
Pan-DENV protein sequence and 
the predicted HLA supertype-
restricted binding nonamer(s) a 
HLA supertype-restriction of predicted nonamer peptide b 
Class I c Class II d 
NetCTL ANN SMM NN-align SMM-align 
97VDRGWGNGCGLFGKG111      
99RGWGNGCGL107 B7 _ B27 _ _ 
99RGWGNGCGLF108 _  A24 _ _ 
99RGWGNGCGLFGK110 _ A03 A01 _ _ 
100GWGNGCGL107 _ _ A24 _ _ 
100GWGNGCGLF108 A24 A24, A01 B62, 
A24 
_ _ 
100GWGNGCGLFGK110 _ _ A03 _ _ 
252VLGSQEGAMH261      
252VLGSQEGA259 _ _ A24 _ _ 
252VLGSQEGAM260 _ _ B62   
 
Table 7. Intra-type representation of candidate putative HLA supertype-restricted nonamer peptides predicted by immune-
informatics algorithms. a Amino acid positions of the pan-DENV sequences and the predicted nonamers are numbered 
according to the sequence alignments of the 4 DENV types; b Rounded to whole number. 
Pan-DENV protein sequence and the 
predicted HLA supertype-restricted 
binding nonamer(s) a 
Intra-type representation (%) b and total sequences analyzed (#) 
DENV-1 DENV-2 DENV-3 DENV-4 
97VDRGWGNGCGLFGKG111  
99RGWGNGCGL107 100/131 100/218 99.5/164 99.4/155 
99RGWGNGCGLF108 100/131 100/218 99.5/164 99.4/155 
99RGWGNGCGLFGK110 100/131 100/218 99.5/164 99.4/155 
100GWGNGCGL107 100/131 100/218 99.5/164 99.4/155 
100GWGNGCGLF108 100/131 100/218 99.5/164 99.4/155 
100GWGNGCGLFGK110 100/131 100/218 99.5/164 99.4/155 
252VLGSQEGAMH261  
252VLGSQEGA259 100/131 99.1/218 100/164 100/155 
252VLGSQEGAM260 100/131 99.1/218 100/164 100/155 
 
DISCUSSION 
 In this study, highly conserved pan-DENV 
sequences in all collected DENV database were 
identified and characterized. A large number of 
sequences analyzed (688), and their wide distribution 
in term of geography and time (1961 – 2012), 
provided decent information for a board survey of 
DENV protein diversity in nature. The 2 pan-DENV 
protein sequences of at least 9 amino acids, covering 
25 amino acids or 5% of the complete DENV E 
protein, were conserved in ≥95% of the collected 
DENV sequences. Both of them are structural 
proteins and belong to the domain II of DENV 
Journal of Biotechnology 14(4): 605-618, 2016 
615 
envelope, responsible for fusion/dimerization 
process (Allison et al., 2001). These conserved 
sequences have shown remarkable stability over the 
entire database, as illustrated by their low entropy 
values and variant frequencies. Moreover, both of 
the pan-DENV sequences were conserved in 25 
other Flavivirus, this provided more evidences of 
prolonged evolutionary stability within this genus 
(Henchal &Putnak 1990; Kuno et al., 1998; Billoir et 
al., 2000). It is possible that these pan-DENV 
sequences withstand selection pressure to maintain 
important biological and/or structural properties; in 
this case, it is fusion peptide and dimerization 
domain (Allison et al., 2001; Modis et al., 2004). 
Hence, these conserved sequences are unlikely to 
significantly diverge in newly emerging DENV 
isolates in the future, and represent attractive targets 
for the vaccine development. 
 Furthermore, there is also evidence that many of 
the conserved sequences are immunologically 
relevant. Putative T-cell epitopes for 6 HLA class I 
supertypes with board application to the immune 
responses of human population worldwide, were 
predicted by computational algorithms. Many the 
putative T-cell determinants were predicted to be 
promiscuous to multiple HLA supertypes, in 
addition to multiple alleles of a given HLA 
supertype, for instance, 100GWGNGCGLF108; 
99RGWGNGCGLFGK110 and 99RGWGNGCGL107 
(Table 6). 
 The dramatic sequence variations between the 
proteins of the 4 DENV types represent a fundamental 
issue for the development of a polyvalent DENV 
vaccine that provides effective protection against each 
DENV type. Based on the MSA result, the sequences 
generally exhibit low intra-type but high inter-type 
variability. This observation is consistent with the other 
results concerning the viral diversity of envelope 
protein which can obstruct developing a polyvalent 
dengue virus vaccine (Livingston, et al., 1995; 
Rothman, 2004) due to alternative determinants, or 
altered peptide ligands (Sloan-Lancaster and Allen, 
1996). Furthermore, the phylogenetic tree revealed that 
DENV-4 is the most evolved and divergent among the 
4 serotypes. In this particular study, this phenomenon 
caused many obstacles in the selection of conserved 
regions, significantly reducing many potential 
candidates. Some of them were already conserved in 3 
DENV serotype but only different in 1 amino acid of 
DENV-4 sequence, thus failed to comply consensus-
based approach (Novitsky et al., 2002).  
 Ultimately, while the immune correlates of 
DENV protection are still poorly understood, some 
researchers suggested that both neutralizing antibody 
and specific T-cell responses are required (Rothman, 
2004; Whitehead et al., 2007). In order to improve 
vaccine efficiency, the introduction of well-defined 
HLA-restricted epitopes within DENV vaccine 
candidates could be a good strategy, thus, providing 
significant boost T-cell help positively to elicit a 
strong, long-lived immunity. For polyvalent 
formulations, it may be relevant to focus primarily 
on sequences that are conserved in all 4 DENV types 
and to avoid the regions of T-cell immunity that are 
highly variable, unless they are strictly type-specific, 
like in the case of DENV-4. Still, the two pan-
DENV E sequences (E 97–111 and E 252– 261) are 
good candidate sequences for neutralizing antibody 
responses. However, in the future, population 
coverage calculation of these pan-DENV sequences 
are needed since an additional criterion for the 
selection of T-cell targets is the need for 
determinants with broad HLA representation, as it 
has been emphasized in the recognition of HLA 
supertypes (Sette & Sidney 1999; Sette et al., 2001; 
Khan et al., 2006). In addition, further wet lab 
investigations are needed to validate the 
immunogenicity of the candidate T-cell determinants 
in human subjects, and to identify sequences 
associated with deleterious T-cell responses. 
CONCLUSION 
 This study aimed to identify and analyze 
conserved regions within the DENV E protein of 4 
different serotypes to serve as potential epitope-
based vaccine targets. 2 peptide regions of at least 9 
amino acids were revealed to be highly conserved 
and identical in more than 95% of all collected 
DENV sequences. Both of them were found to be 
immune-relevant by their correspondence to known 
or putative HLA-restricted T cell determinants. Their 
level of conservation of these sequences was 
analyzed by many bioinformatics algorithms.  The 
final results support their potential as candidates; 
however, wet-lab experiments are also necessary to 
validate the immunogenicity of the candidate T-cell 
epitopes. Still, this study is not complete yet. There 
are many things can be done to improve this 
approach such as 3-D structures of DENV E protein, 
identification of optimum binding HLA supertypes 
and population coverage. Furthermore, relationships 
with other species should also be considered in case 
these two regions show positive results in wet-lab 
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experiments. Another recommendation is that 
researches in the future should focus on DENV-4 
and DENV-2. Since DENV-2 is the most evolved 
and divergent among 4 serotypes, and DEN-2 is the 
most popular and widespread. Finally, with some 
advance tweaks, this computational approach can 
also be applied to identify vaccine targets for other 
types of virus. 
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